Literature DB >> 12039494

Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome.

Munetake Kanda1, Wataru Shimizu, Kiyotaka Matsuo, Noritoshi Nagaya, Atsushi Taguchi, Kazuhiro Suyama, Takashi Kurita, Naohiko Aihara, Shiro Kamakura.   

Abstract

OBJECTIVES: The study examined the electrocardiographic and electrophysiologic characteristics in relation to programmed ventricular stimulation (PVS)-induced ventricular fibrillation (VF), as well as the implications of PVS-induced VF on the recurrence of cardiac events in symptomatic Brugada syndrome.
BACKGROUND: Brugada syndrome is characterized by ST-segment elevation in the right precordial leads (V(1)-V(3)) and an episode of VF.
METHODS: Thirty-four symptomatic patients with Brugada syndrome (33 men and 1 woman; 44 +/- 12 years old) were classified into two groups according to the inducibility of VF with PVS: 22 patients with induced VF requiring direct cardioversion for termination (Induced VF group) and 12 patients without induced VF (Noninduced VF group).
RESULTS: The induced VF group showed a longer QRS duration, a higher incidence of right bundle branch block and late potentials detected on the signal-averaged electrocardiogram, longer His-ventricular intervals and a longer conduction time from the RVOT to the left ventricle at extrastimulation than those in the non-induced VF group. However, there was no significant difference in the recurrence of cardiac events (VF documented by an implantable cardioverter-defibrillator and sudden cardiac death) between the two groups (8 [36%] of 22 patients vs. 7 [58%] of 12 patients) during long-term follow-up (range 1 to 149 months; mean 38).
CONCLUSIONS: Our data suggest that induction of VF by PVS depends on the severity of depolarization abnormalities but does not predict the recurrence of cardiac events in symptomatic Brugada syndrome, indicating that both depolarization and repolarization abnormalities are important in the development of VF.

Entities:  

Mesh:

Year:  2002        PMID: 12039494     DOI: 10.1016/s0735-1097(02)01867-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

1.  A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice.

Authors:  Thomas J Hund; Olha M Koval; Jingdong Li; Patrick J Wright; Lan Qian; Jedidiah S Snyder; Hjalti Gudmundsson; Crystal F Kline; Nathan P Davidson; Natalia Cardona; Matthew N Rasband; Mark E Anderson; Peter J Mohler
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

Review 2.  Right bundle branch block and conduction disturbances in Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy.

Authors:  Leonardo Calò; Annamaria Martino; Emilia Goanta; Yasuo Okumura; Ermenegildo de Ruvo
Journal:  J Interv Card Electrophysiol       Date:  2018-05-26       Impact factor: 1.900

3.  The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization.

Authors:  Arthur A M Wilde; Pieter G Postema; José M Di Diego; Sami Viskin; Hiroshi Morita; Jeffrey M Fish; Charles Antzelevitch
Journal:  J Mol Cell Cardiol       Date:  2010-07-24       Impact factor: 5.000

Review 4.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

5.  Persistent abnormal value of late potential in Brugada syndrome associated with hypokalemia.

Authors:  Daisuke Kutsuzawa; Takanori Arimoto; Tetsu Watanabe; Joji Nitobe; Takuya Miyamoto; Takehiko Miyashita; Tetsuro Shishido; Hiroki Takahashi; Satoshi Nishiyama; Isao Kubota
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

Review 6.  Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.

Authors:  Wataru Shimizu; Takeshi Aiba; Charles Antzelevitch
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 7.  Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes.

Authors:  Ilan Goldenberg; Arthur J Moss; Wojciech Zareba
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

8.  [52-year old patient with recurrent syncope and temporary right precordial EKG-changes with fever].

Authors:  R Caliskan; M Zabel; B Witzenbichler; C Sticherling
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

9.  Identifying patterns of spatial current dispersion that characterise and separate the Brugada syndrome and complete right-bundle branch block.

Authors:  A Kandori; W Shimizu; M Yokokawa; T Noda; S Kamakura; K Miyatake; M Murakami; T Miyashita; K Ogata; K Tsukada
Journal:  Med Biol Eng Comput       Date:  2004-03       Impact factor: 2.602

10.  [Brugada ECG].

Authors:  Sergio Richter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.